Oya S, Ozawa H, Morishige S, Maehiro Y, et al. High-dose cytarabine plus gemtuzumab ozogamicin as consolidation therapy in patients with favorable- or intermediate-risk acute myeloid leukemia. Int J Hematol 2024 Jul 4. doi: 10.1007/s12185-024-03814.
PMID: 38963637